Fuller & Thaler Asset Management, Inc. Catalent, Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$40.12 - $45.55 $4.13 Million - $4.69 Million	-103,060 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$38.72 - $42.52 $1.76 Million - $1.93 Million	-45,340 Reduced 30.55%	103,060 $4.32 Million
Q1 2018 May 14, 2018	SELL	$39.4 - $47.39 $3.24 Million - $3.9 Million	-82,300 Reduced 35.67%	148,400 $6.09 Million
Q4 2017 Feb 12, 2018	BUY	$37.27 - $43.02 $5.45 Million - $6.29 Million	146,100 Added 172.7%	230,700 $9.48 Million
Q3 2017 Nov 08, 2017	BUY	$33.75 - $41.67 $2.86 Million - $3.53 Million	84,600	84,600 $3.38 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.